A medical device company for patients with respiratory failure. Developing the Hemolung Respiratory Assist System (RAS), a dialysis-like alternative or supplement to mechanical ventilation.
ALung’s Hemolung RAS was originally developed at the University of Pittsburgh. The device is limited by United StatesUnited States law to investigational use. ALung is conducting a pivotal investigational device exemption trial of the Hemolung Respiratory Assist System for the treatment of adults with severe acute exacerbations of chronic obstructive pulmonary disease (COPD). The VENT-AVOID Trial is the first pivotal trial of extracorporeal carbon dioxide removal (ECCO2R) for treating patients with COPD exacerbations.